Jason Ku Wang
Biotech Investor at Paradigm BioCapital
New York City Metropolitan Area
Overview
Jason Ku Wang is a Biotech Investor at Paradigm BioCapital in the New York City Metropolitan Area. With a background in medicine and experience at prestigious firms like 5AM Ventures and PathAI, he brings a unique blend of scientific knowledge and investment expertise to his role. Wang's career highlights include being a Paul & Daisy Soros Fellow at Harvard Medical School and completing a management science program at Schwarzman Scholars.
Work Experience
Analyst
2022 - Current
Consultant
2021 - 2022
Fellow
2020 - 2021
5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.
Research
2020 - 2021
PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.
Raised $355,200,000.00 from General Atlantic, LabCorp, General Catalyst, Adage Capital Management, Refactor, Kaiser Permanente, Bienville Capital, Biospring Partners, Bristol-Myers Squibb and Merck Global Health Innovation Fund.